Navigation Links
Cell Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants
Date:7/22/2009

ffer, solicitation or sale is unlawful.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect the actual future results of the Company and the trading price of securities of the Company. The risks and uncertainties include the risk that the offering might not be completed or might be completed on terms different from those described above, the investors might not exercise their warrants, the Company might not be able to continue to raise additional capital as needed to fund its operations, the Company's intentions regarding the use of proceeds, and other risk factors listed or described from time to time in the Company's filings with the SEC, including, without limitation, its most recent filings on Forms 10-K, 10-Q and 8-K. Except as required by law, the Company does not intend to update any of the statements in this press release upon further developments.

    Media Contact:

    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    E: media@ctiseattle.com
    www.CellTherapeutics.com/press_room


    Investors Contact:

    Ed Bell
    T: 206.272.4345

    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.CellTherapeutics.com/investors


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Oxygen Biotherapeutics, Inc. Announces Closing of Offer to Acquire Warrants
2. QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement
3. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
4. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
5. Prospect Therapeutics, Inc.s GCS-100 Exhibits a Low Toxicity Profile in Cancer Patients
6. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
7. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants
8. Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
9. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
10. TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
11. Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... will be donated to the Lupus Foundation of America ... WASHINGTON, Dec. 15 Julian Lennon, son of ... released their new digital single, "LUCY," to raise funds ... March 15, 2010, 100 percent of the proceeds from ... Lupus Foundation of America (LFA), and the Saint Thomas, ...
(Date:12/15/2009)... High levels of leptin associated with lower dementia risk, ... High blood levels of leptin, a hormone that regulates ... , "Hopefully, in 10 or 15 years this may ... reduce the risk of Alzheimer,s disease," said senior study ... at Boston University School of Medicine. "Or it may ...
(Date:12/15/2009)... but not delivered ,, WASHINGTON, Dec. 15 ... to ensure that healthcare reform does not override ... insurance companies in 37 states. ,, Prostate cancer ... the population and individuals who are identifiable as ... who have a family history of prostate cancer. ...
(Date:12/15/2009)... PLAINS, N.Y., Dec. 15 Team In ... groundbreaking charity sports training program, has ... to support blood cancer research and patient services. ... been the pre-eminent charity endurance sports training program, ... marathon, half marathon, triathlon, 100-mile century cycle ride ...
(Date:12/15/2009)... -- North American application activity for individually underwritten ... to the MIB Life Index(SM) . ... past three months have lifted year-to-date (YTD) figures ... flat at November,s close, -0.1%. "It is ... benefits available from life insurance," says Stacy Gill, ...
Breaking Medicine News(10 mins):Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... Technologies (OTC Bulletin Board: PSTX) today announced that ... senior notes with net proceeds of $2.0 million. ... towards funding the continued growth of its primary ... of tracking systems for surgical sponges."As hospitals face ...
... Angeles-based HR Consulting firm, a new white paper reveals how small businesses ... ... (PRWEB) January 30, 2009 -- Due to a grim economic forecast for ... help relieve their recession woes. This is according to a new white ...
... 10 tips for getting through the backlog to help claimants with ... ... 2009 -- The increase in people applying for Social Security disability ... their entitled benefits, according to Allsup , which represents tens ...
... and Future Growth Opportunities in Transplant Diagnostics and Genetic ... 30 Gen-Probe Incorporated (Nasdaq: GPRO ), ... human disease, announced today that it has offered to ... Life Sciences, PLC (AIM: TED), a rapidly growing molecular ...
... Tobacco-Free KidsWASHINGTON, Jan. 29 The U.S. ... by voting to increase federal tobacco taxes, including a ... and expansion of the State Children,s Health Insurance ... future for millions of children both by reducing tobacco ...
... presented today at the American,Academy of Pain Medicine,s ... about pain during the experience of pain, and ... the central,nervous system that mediate pain sensations. ... Previous studies have looked at physiological,responses to ...
Other Medicine News:Health News:CPEhr Releases New White Paper Highlighting Value of Human Resources Outsourcing In A Recession 2Health News:CPEhr Releases New White Paper Highlighting Value of Human Resources Outsourcing In A Recession 3Health News:Applications for Social Security Disability Reach 2.6 Million 2Health News:Applications for Social Security Disability Reach 2.6 Million 3Health News:Applications for Social Security Disability Reach 2.6 Million 4Health News:Applications for Social Security Disability Reach 2.6 Million 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 2Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 3Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 4Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 5Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 6Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 7Health News:Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash 8Health News:U.S. Senate Acts to Protect Kids, Save Lives by Increasing Federal Tobacco Taxes 2Health News:Negative Emotions About Pain Increase Pro-Inflammatory Response 2
(Date:12/15/2009)... The U.S. Food and Drug Administration (FDA) ... 12 yes, 4 no, and 1 abstention that AstraZeneca ... to support the use of CRESTOR® (rosuvastatin calcium) in ... than or equal to 50 years, women greater than ... < 130 mg/dL; hsCRP greater than or equal to ...
(Date:12/15/2009)... -- Medical researchers with EDP Biotech Corporation (EDP) ... technology for a simple blood test to detect ... success of its pre-clinical trials for the ColoMarker(TM) ... biomarker, CA11-19, and all aspects of its use. ... detect colon cancer in its earliest, most curable ...
(Date:12/15/2009)... Certified healthcare providers who have already immunized patients ... flu virus may now offer the vaccine to ... announced today. ,, Pennsylvania is expanding the ... million doses of vaccine have been allocated to ... the priority groups. ,, "Many certified providers have ...
Breaking Medicine Technology:Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 2Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 3Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 4Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R) (rosuvastatin calcium) in JUPITER Study 5Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2UC Davis study highlights work life issues of female surgeons 52395 1UC Davis study highlights work life issues of female surgeons 52395 2Early rice harvests ease annual famine in Bangladesh 9316 1Early rice harvests ease annual famine in Bangladesh 9316 2Scientists link immune systems natural killer cells to infant liver disease 9312 1Scientists link immune systems natural killer cells to infant liver disease 9312 2
... 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated presented ... showing that tanespimycin demonstrated antitumor,activity and tolerability ... with a BRAF mutation (V600E) who had ... and while on,tanespimycin demonstrated progression-free survival for ...
... 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated presented ... that KOS-1584/R1645, an epothilone under,co-development with Roche, ... with solid tumors.,KOS-1584/R1645 showed activity in 32% ... in patients with non-small cell lung,ovarian, breast, ...
Other Medicine Technology:Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 2Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 3Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 2Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 3Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 5
... (ACE) is an integral part of the ... Angiotensin II as well as the degradation ... types, ACE is primarily located in endothelial ... diagnostic parameter for sarcoidosis and myocardial infarction ...
... Insulin is the principal hormone responsible for the ... in the b-cells of the islets of Langerhans ... form C-peptide and insulin. Both are secreted ... The mature insulin molecule is comprised of two ...
Calcitonin EIA Bone and Mineral Metabolism 021-SDX017...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-96 Proteinase...
Medicine Products: